Hainan Haiyao Co., Ltd. (SHE:000566)
4.190
+0.090 (2.20%)
Oct 23, 2026, 3:04 PM CST
Hainan Haiyao Revenue
Hainan Haiyao had revenue of 153.08M CNY in the quarter ending June 30, 2026, a decrease of -37.18%. This brings the company's total for the last twelve months to 702.17M, down -17.15% year-over-year. In the year 2025, Hainan Haiyao had annual revenue of 831.18M, down -16.10%. That makes Hainan Haiyao the 22,272nd largest company in the world by revenue and 4,060th in China.
Revenue (ttm)
702.17M
Revenue Growth
-17.15%
P/S Ratio
7.74
Revenue / Employee
404.01K
Employees
1,738
Market Cap
5.44B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Hainan Haiyao breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 831.18M | -159.52M | -16.10% |
| Dec 31, 2024 | 990.70M | -487.88M | -33.00% |
| Dec 31, 2023 | 1.48B | -300.47M | -16.89% |
| Jan 1, 2023 | 1.78B | -280.01M | -13.60% |
| Jan 1, 2022 | 2.06B | -141.25M | -6.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Xinbang Pharmaceutical | 5.24B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.73B |
| Hunan Jiudian Pharmaceutical | 2.89B |
| Tianjin Tianyao Pharmaceuticals | 2.54B |
| Shandong Wit Dyne Health | 1.91B |
| Bide Pharmatech | 1.38B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.01B |
| Jiangsu Jibeier Pharmaceutical | 1.00B |